Predictive Oncology Price to Book Ratio 2010-2025 | POAI
Historical price to book ratio values for Predictive Oncology (POAI) over the last 10 years. The current price to book ratio for Predictive Oncology as of September 02, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Predictive Oncology Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2025-09-02 |
0.91 |
|
0.00 |
| 2025-06-30 |
0.83 |
$-0.17 |
-4.82 |
| 2025-03-31 |
1.52 |
$-0.02 |
-93.25 |
| 2024-12-31 |
0.82 |
$-0.03 |
-26.97 |
| 2024-09-30 |
0.79 |
$0.30 |
2.67 |
| 2024-06-30 |
1.04 |
$0.72 |
1.45 |
| 2024-03-31 |
2.55 |
$1.00 |
2.56 |
| 2023-12-31 |
3.29 |
$2.04 |
1.62 |
| 2023-09-30 |
3.20 |
$2.89 |
1.11 |
| 2023-06-30 |
4.86 |
$3.67 |
1.32 |
| 2023-03-31 |
6.54 |
$4.67 |
1.40 |
| 2022-12-31 |
6.14 |
$5.53 |
1.11 |
| 2022-09-30 |
7.20 |
$7.55 |
0.95 |
| 2022-06-30 |
8.20 |
$8.58 |
0.96 |
| 2022-03-31 |
19.54 |
$11.28 |
1.73 |
| 2021-12-31 |
19.04 |
$12.27 |
1.55 |
| 2021-09-30 |
26.60 |
$14.60 |
1.82 |
| 2021-06-30 |
26.20 |
$16.25 |
1.61 |
| 2021-03-31 |
24.20 |
$14.57 |
1.66 |
| 2020-12-31 |
14.64 |
$2.67 |
5.49 |
| 2020-09-30 |
16.28 |
$14.75 |
1.10 |
| 2020-06-30 |
32.80 |
$17.73 |
1.85 |
| 2020-03-31 |
31.50 |
$35.38 |
0.89 |
| 2019-12-31 |
52.20 |
$55.37 |
0.94 |
| 2019-09-30 |
101.00 |
$131.53 |
0.77 |
| 2019-06-30 |
149.60 |
$143.93 |
1.04 |
| 2019-03-31 |
150.00 |
$0.81 |
185.99 |
| 2018-12-31 |
123.80 |
$0.76 |
163.13 |
| 2018-09-30 |
212.00 |
$45.18 |
4.69 |
| 2018-06-30 |
226.00 |
$55.62 |
4.06 |
| 2018-03-31 |
220.00 |
$88.37 |
2.49 |
| 2017-12-31 |
202.00 |
$77.54 |
2.61 |
| 2017-09-30 |
290.80 |
$73.22 |
3.97 |
| 2017-06-30 |
294.00 |
$103.39 |
2.84 |
| 2017-03-31 |
420.00 |
$122.75 |
3.42 |
| 2016-12-31 |
560.00 |
$40.48 |
13.84 |
| 2016-09-30 |
825.00 |
$0.68 |
1219.87 |
| 2016-06-30 |
765.00 |
$50.53 |
15.14 |
| 2016-03-31 |
865.00 |
$237.65 |
3.64 |
| 2015-12-31 |
14700.00 |
$19.77 |
743.63 |
| 2015-09-30 |
16070.00 |
$1.12 |
14366.17 |
| 2015-06-30 |
15500.00 |
$-1.86 |
-8349.49 |
| 2015-03-31 |
17250.00 |
$-1.77 |
-9768.39 |
| 2014-12-31 |
32500.00 |
$-1.79 |
-18205.24 |
| 2014-09-30 |
41250.00 |
$-1.28 |
-32226.56 |
| 2014-06-30 |
56250.00 |
$-72.32 |
-777.78 |
| 2014-03-31 |
69375.00 |
$-37.28 |
-1860.97 |
| 2013-12-31 |
101250.00 |
$-1.10 |
-92179.53 |
| 2013-09-30 |
119250.00 |
$-27.51 |
-4334.11 |
| 2013-06-30 |
56250.00 |
$-143.15 |
-392.94 |
| 2013-03-31 |
53250.00 |
$-118.23 |
-450.40 |
| 2012-12-31 |
45000.00 |
$-158.43 |
-284.03 |
| 2012-09-30 |
28125.00 |
$-113.02 |
-248.85 |
| 2012-06-30 |
24375.00 |
$-168.47 |
-144.69 |
| 2012-03-31 |
18750.00 |
$-382.18 |
-49.06 |
| 2011-12-31 |
105000.00 |
$-421.41 |
-249.16 |
| 2011-09-30 |
131250.00 |
$-424.64 |
-309.09 |
| 2011-06-30 |
33750.00 |
$-517.19 |
-65.26 |
| 2011-03-31 |
36000.00 |
$-522.52 |
-68.90 |
| 2010-12-31 |
41250.00 |
$-781.87 |
-52.76 |
| 2010-09-30 |
63750.00 |
$-755.13 |
-84.42 |
| 2010-06-30 |
80625.00 |
$-782.44 |
-103.04 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.010B |
$0.002B |
|
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
|
